Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rettinger

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Progress in Brain Research|November 7, 1999
Novel ligands for P2 receptor subtypes in innervated tissuesG Lambrecht, S Damer, B Niebel, et al.
European Journal of Pharmacology|July 31, 1998
NF279: a novel potent and selective antagonist of P2X receptor-mediated responsesS Damer, B Niebel, S Czeche, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 25, 2001
NF449: a subnanomolar potency antagonist at recombinant rat P2X1 receptorsK Braun, J Rettinger, M Ganso, et al.
European Journal of Pharmacology|January 29, 2000
The novel pyridoxal-5'-phosphate derivative PPNDS potently antagonizes activation of P2X(1) receptorsG Lambrecht, J Rettinger, H G Bäumert, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Progress in Brain Research|November 7, 1999
Novel ligands for P2 receptor subtypes in innervated tissuesG Lambrecht, S Damer, B Niebel, et al.
European Journal of Pharmacology|July 31, 1998
NF279: a novel potent and selective antagonist of P2X receptor-mediated responsesS Damer, B Niebel, S Czeche, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 25, 2001
NF449: a subnanomolar potency antagonist at recombinant rat P2X1 receptorsK Braun, J Rettinger, M Ganso, et al.
European Journal of Pharmacology|January 29, 2000
The novel pyridoxal-5'-phosphate derivative PPNDS potently antagonizes activation of P2X(1) receptorsG Lambrecht, J Rettinger, H G Bäumert, et al.
Pageof 2